The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
Publications
Drug-induced eosinophilic pneumonia: high-resolution CT findings in 14 patients.
AJR. American journal of roentgenology. 2006;186(2):368-73
Allergic reactions to para-aminosalicylic acid; report of seven cases, including one case of Löffler's syndrome.
American review of tuberculosis. 1952;65(3):235-49
Loeffler's syndrome due to paraaminosalicylic acid.
Diseases of the chest. 1962;42:100-3
Complications in the chemotherapy of tuberculosis. A review with analysis of the experience of 3,148 patients.
The American review of respiratory disease. 1961;83:359-71
Lung infiltrations as a complication of PAS treatment.
Tubercle. 1958;39(3):169-71
Allergic (Löffler's) pneumonitis occurring during antituberculous chemotherapy; report of three cases.
American review of tuberculosis. 1956;74(3):445-53
Allergic pneumonitis during chemotherapy for tuberculosis: report of two cases due to paraaminosalicylic acid.
Annals of internal medicine. 1955;42(1):190-7
Löffler's reaction to para-aminosalicylic acid.
American review of tuberculosis. 1954;70(1):171-5
The lung in inflammatory bowel disease.
Medicine. 1993;72(3):151-83